Sign inJoin
Company / Finance

Bristol Myers Squibb Company

BMY · NYSE

Bristol Myers Squibb reported Q1 2026 revenue of $11.49 billion, net income of $2.68 billion and cash of $9.57 billion. The thesis depends on new product growth, loss-of-exclusivity management, pipeline execution and debt/cash discipline.

FollowAdd to WatchlistAsk Question
NYSEBMYCoverage BootstrapBristol Myers Squibb Company
Latest ReportMay 20, 2026Bristol Myers: the patent cliff has to meet a real pipeline bridgeView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.

Sign in as admin